Disease | vasculitis |
Phenotype | C0024440|cystoid macular edema |
Sentences | 1 |
PubMedID- 21799465 | Conclusion: intravitreal injection of bevacizumab seems to be well tolerated and is associated with short-term improvement of visual acuity and decreased retinal thickness in patients with cystoid macular edema because of vasculitis that is resistant to conventional therapy. |
Page: 1